Company Filing History:
Years Active: 2025
Title: Emily Joy Pomeroy: Innovator in Gene Editing Technology
Introduction
Emily Joy Pomeroy is a prominent inventor based in Minneapolis, MN (US). She has made significant contributions to the field of gene editing, particularly in the area of lymphohematopoietic engineering. Her innovative work has the potential to impact therapeutic applications in immunotherapy.
Latest Patents
Emily holds a patent for "Lymphohematopoietic engineering using CAS9 base editors." This patent outlines methods and systems for targeted gene disruption and targeted gene knock-in in mammalian cells. The technology utilizes base editors and guide RNAs (gRNAs) designed to target splice acceptor-splice donor sites. Additionally, her patent includes genetically engineered cells with targeted disruptions in immunotherapy-related genes, which comprise a CAR/TCR for therapeutic applications. She has 1 patent to her name.
Career Highlights
Emily is affiliated with the University of Minnesota, where she conducts her research and development in gene editing technologies. Her work is at the forefront of scientific innovation, contributing to advancements in medical therapies.
Collaborations
Some of her notable coworkers include Branden Moriarity and Beau R Webber, who collaborate with her on various projects related to gene editing and immunotherapy.
Conclusion
Emily Joy Pomeroy is a trailblazer in the field of gene editing, with her innovative patent paving the way for future advancements in immunotherapy. Her contributions are vital to the ongoing evolution of genetic engineering technologies.